572 related articles for article (PubMed ID: 19160109)
1. Decidual immune cell infiltrate in hydatidiform mole.
Hussein MR; Abd-Elwahed AR; Abodeif ES; Abdulwahed SR
Cancer Invest; 2009 Jan; 27(1):60-6. PubMed ID: 19160109
[TBL] [Abstract][Full Text] [Related]
2. Decidual infiltration of FoxP3⁺ regulatory T cells, CD3⁺ T cells, CD56⁺ decidual natural killer cells and Ki-67 trophoblast cells in hydatidiform mole compared to normal and ectopic pregnancies.
Sundara YT; Jordanova ES; Hernowo BS; Gandamihardja S; Fleuren GJ
Mol Med Rep; 2012 Jan; 5(1):275-81. PubMed ID: 22002546
[TBL] [Abstract][Full Text] [Related]
3. No evidence for apoptosis of decidual leucocytes in normal and molar pregnancy: implications for immune privilege.
Pongcharoen S; Bulmer JN; Searle RF
Clin Exp Immunol; 2004 Nov; 138(2):330-6. PubMed ID: 15498045
[TBL] [Abstract][Full Text] [Related]
4. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
Hussein MR
Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
[TBL] [Abstract][Full Text] [Related]
5. Decidual T lymphocyte activation in hydatidiform mole.
Wongweragiat S; Searle RF; Bulmer JN
J Clin Pathol; 1999 Dec; 52(12):888-94. PubMed ID: 10711251
[TBL] [Abstract][Full Text] [Related]
6. Expression of Fas/Fas ligand by decidual leukocytes in hydatidiform mole.
Wongweragiat S; Searle RF; Bulmer JN
Biol Reprod; 2001 Mar; 64(3):784-9. PubMed ID: 11207192
[TBL] [Abstract][Full Text] [Related]
7. Immune cell profile in invasive cholesteatomas: preliminary findings.
Hussein MR; Sayed RH; Abu-Dief EE
Exp Mol Pathol; 2010 Apr; 88(2):316-23. PubMed ID: 20045407
[TBL] [Abstract][Full Text] [Related]
8. Analysis of RCAS1 immunoreactivity within hydatidiform mole cells and decidual cells according to the applied therapeutic strategy: surgery or surgery followed by chemotherapy.
Wicherek L; Basta P; Wertel I; Kojs Z; Malkowski B; Grabiec M; Pietrus M; Krystyna G
Gynecol Obstet Invest; 2012; 73(2):106-12. PubMed ID: 22269478
[TBL] [Abstract][Full Text] [Related]
9. Imbalance of mononuclear cell infiltrates in the placental tissue from foetuses after spontaneous abortion versus therapeutic termination from 8th to 12th weeks of gestational age.
Lambropoulou M; Tamiolakis D; Venizelos J; Liberis V; Galazios G; Tsikouras P; Karamanidis D; Petrakis G; Constantinidis T; Menegaki M; Papadopoulos N
Clin Exp Med; 2006 Dec; 6(4):171-6. PubMed ID: 17191109
[TBL] [Abstract][Full Text] [Related]
10. The villous stromal constituents of complete hydatidiform mole differ histologically in very early pregnancy from the normally developing placenta.
Kim KR; Park BH; Hong YO; Kwon HC; Robboy SJ
Am J Surg Pathol; 2009 Feb; 33(2):176-85. PubMed ID: 18936691
[TBL] [Abstract][Full Text] [Related]
11. Immune cell profiling in normal pregnancy, partial and complete molar pregnancy.
Nagymanyoki Z; Callahan MJ; Parast MM; Fulop V; Mok SC; Berkowitz RS
Gynecol Oncol; 2007 Nov; 107(2):292-7. PubMed ID: 17878059
[TBL] [Abstract][Full Text] [Related]
12. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
13. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.
Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES
BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma.
Hussein MR; Al-Assiri M; Musalam AO
Exp Mol Pathol; 2009 Apr; 86(2):108-13. PubMed ID: 19111537
[TBL] [Abstract][Full Text] [Related]
15. Plasma homocysteine, vitamin B12 and folate levels in hydatidiform moles and histopathological subtypes.
Kokanali MK; Oztürkkan D; Unsal N; Möroy P; Güngör T; Mollamahmutoğlu L
Arch Gynecol Obstet; 2008 Dec; 278(6):531-4. PubMed ID: 18379803
[TBL] [Abstract][Full Text] [Related]
16. Complete hydatidiform mole. Comparison of clinicopathologic features, current and past.
Mosher R; Goldstein DP; Berkowitz R; Bernstein M; Genest DR
J Reprod Med; 1998 Jan; 43(1):21-7. PubMed ID: 9475145
[TBL] [Abstract][Full Text] [Related]
17. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
Kale A; Söylemez F; Ensari A
Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
[TBL] [Abstract][Full Text] [Related]
18. Distribution of immunocompetent cells in decidua of controlled and uncontrolled (choriocarcinoma/hydatidiform mole) trophoblast invasion.
Knoeller S; Lim E; Aleta L; Hertwig K; Dudenhausen JW; Arck PC
Am J Reprod Immunol; 2003 Jul; 50(1):41-7. PubMed ID: 14506927
[TBL] [Abstract][Full Text] [Related]
19. Incidence of acute atherosis in complete molar pregnancy.
Hayati AR; Azizah A; Wahidah A
Malays J Pathol; 1998 Dec; 20(2):113-4. PubMed ID: 10879273
[TBL] [Abstract][Full Text] [Related]
20. Age related cellular immune response against complete molar pregnancy.
Nagymanyoki Z; Kindelberger D; Clark R; Rodriguez N; Fulop V; Berkowitz RS
J Reprod Med; 2010; 55(5-6):261-6. PubMed ID: 20626184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
